ASND
Price
$228.03
Change
+$0.16 (+0.07%)
Updated
Oct 5 closing price
Capitalization
15.13B
36 days until earnings call
Intraday BUY SELL Signals
LSTA
Price
$1.26
Change
-$0.21 (-14.29%)
Updated
Oct 5 closing price
Capitalization
16.21M
30 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ASND vs LSTA

ASND vs LSTA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ASND vs. LSTA commentary
Oct 06, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASND is a Hold and LSTA is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ASND vs LSTA: Fundamental Ratings
ASND
LSTA
OUTLOOK RATING
1..100
6393
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
61100
SMR RATING
1..100
1299
PRICE GROWTH RATING
1..100
6190
P/E GROWTH RATING
1..100
82100
SEASONALITY SCORE
1..100
508

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LSTA's Valuation (40) in the null industry is somewhat better than the same rating for ASND (76) in the Biotechnology industry. This means that LSTA’s stock grew somewhat faster than ASND’s over the last 12 months.

ASND's Profit vs Risk Rating (61) in the Biotechnology industry is somewhat better than the same rating for LSTA (100) in the null industry. This means that ASND’s stock grew somewhat faster than LSTA’s over the last 12 months.

ASND's SMR Rating (12) in the Biotechnology industry is significantly better than the same rating for LSTA (99) in the null industry. This means that ASND’s stock grew significantly faster than LSTA’s over the last 12 months.

ASND's Price Growth Rating (61) in the Biotechnology industry is in the same range as LSTA (90) in the null industry. This means that ASND’s stock grew similarly to LSTA’s over the last 12 months.

ASND's P/E Growth Rating (82) in the Biotechnology industry is in the same range as LSTA (100) in the null industry. This means that ASND’s stock grew similarly to LSTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASNDLSTA
RSI
ODDS (%)
Bullish Trend 1 day ago
71%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
73%
Bearish Trend 1 day ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
81%
COMPARISON
Comparison
Oct 06, 2026
Stock price -- (ASND: $228.03 vs. LSTA: $1.26)
Brand notoriety: ASND and LSTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASND: 136% vs. LSTA: 24%
Market capitalization -- ASND: $15.13B vs. LSTA: $16.21M
ASND [@Biotechnology] is valued at $15.13B. LSTA’s [@Biotechnology] market capitalization is $16.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASND’s FA Score shows that 1 FA rating(s) are green while LSTA’s FA Score has 0 green FA rating(s).

  • ASND’s FA Score: 1 green, 4 red.
  • LSTA’s FA Score: 0 green, 5 red.
According to our system of comparison, ASND is a better buy in the long-term than LSTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASND’s TA Score shows that 5 TA indicator(s) are bullish while LSTA’s TA Score has 5 bullish TA indicator(s).

  • ASND’s TA Score: 5 bullish, 5 bearish.
  • LSTA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, LSTA is a better buy in the short-term than ASND.

Price Growth

ASND (@Biotechnology) experienced а -0.88% price change this week, while LSTA (@Biotechnology) price change was -16.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.37%. For the same industry, the average monthly price growth was -13.88%, and the average quarterly price growth was -3.26%.

Reported Earning Dates

ASND is expected to report earnings on Nov 11, 2026.

LSTA is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-3.37% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ASND
Daily Signal:
Gain/Loss:
LSTA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LZ5.870.27
+4.82%
LegalZoom.com
BOX35.340.85
+2.46%
BOX
PASW0.13N/A
+1.84%
Ping An Biomedical Co. Ltd.
DHX4.81N/A
N/A
DHI Group
UAL110.00-2.51
-2.23%
United Airlines Holdings

ASND and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASND has been loosely correlated with ORMP. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ASND jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASND
1D Price
Change %
ASND100%
+0.07%
ORMP - ASND
37%
Loosely correlated
+1.34%
AMRN - ASND
35%
Loosely correlated
-2.11%
AXON - ASND
34%
Loosely correlated
-0.37%
TARS - ASND
34%
Loosely correlated
+1.99%
BCYC - ASND
34%
Loosely correlated
+18.64%
More

LSTA and

Correlation & Price change

A.I.dvisor tells us that LSTA and PYPD have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LSTA and PYPD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSTA
1D Price
Change %
LSTA100%
-14.29%
PYPD - LSTA
30%
Poorly correlated
+0.19%
RAIN - LSTA
29%
Poorly correlated
-1.44%
MLEC - LSTA
27%
Poorly correlated
+0.83%
ASND - LSTA
26%
Poorly correlated
+0.07%
AMLX - LSTA
25%
Poorly correlated
-0.04%
More